• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于健康组织、肝细胞癌及其他病变的动态镓- FAPI - 04 PET/CT成像的方法学研究。

A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic Ga-FAPI-04 PET/CT imaging.

作者信息

Geist Barbara Katharina, Xing Haiqun, Wang Jingnan, Shi Ximin, Zhao Haitao, Hacker Marcus, Sang Xinting, Huo Li, Li Xiang

机构信息

Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, 100730, China.

出版信息

EJNMMI Phys. 2021 Jan 22;8(1):8. doi: 10.1186/s40658-021-00353-y.

DOI:10.1186/s40658-021-00353-y
PMID:33483880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7822999/
Abstract

BACKGROUND

The study aimed to establish a Ga-FAPI-04 kinetic model in hepatic lesions, to determine the potential role of kinetic parameters in the differentiation of hepatocellular carcinoma (HCC) from non-HCC lesions.

MATERIAL AND METHODS

Time activity curves (TACs) were extracted from seven HCC lesions and five non-HCC lesions obtained from Ga-FAPI-04 dynamic positron emission tomography (PET) scans of eight patients. Three kinetic models were applied to the TACs, using image-derived hepatic artery and/or portal vein as input functions. The maximum standardized uptake value (SUV) was taken for the lesions, the hepatic artery, and for the portal veins-the mean SUV for all healthy regions. The optimum model was chosen after applying the Schwartz information criteria to the TACs, differences in model parameters between HCC, non-HCC lesions, and healthy tissue were evaluated with the ANOVA test.

RESULTS

A reversible two-tissue compartment model using both the arterial as well as venous input function was most preferred and showed significant differences in the kinetic parameters V, V, and BP between HCC, non-HCC lesions, and healthy regions (p < 0.01).

CONCLUSION

Several model parameters derived from a two-tissue compartment kinetic model with two image-derived input function from vein and aorta and using SUV allow a differentiation between HCC and non-HCC lesions, obtained from dynamically performed PET scans using FAPI.

摘要

背景

本研究旨在建立肝脏病变的镓标记的FAPI-04动力学模型,以确定动力学参数在肝细胞癌(HCC)与非HCC病变鉴别诊断中的潜在作用。

材料与方法

从8例患者的镓标记的FAPI-04动态正电子发射断层扫描(PET)图像中获取7个HCC病变和5个非HCC病变的时间-活性曲线(TAC)。将三种动力学模型应用于TAC,以图像导出的肝动脉和/或门静脉作为输入函数。取病变、肝动脉和门静脉的最大标准化摄取值(SUV),所有健康区域取平均SUV。将施瓦茨信息准则应用于TAC后选择最佳模型,采用方差分析评估HCC、非HCC病变和健康组织之间模型参数的差异。

结果

同时使用动脉和静脉输入函数的可逆双组织房室模型最为合适,且HCC、非HCC病变和健康区域之间的动力学参数V、V和BP存在显著差异(p < 0.01)。

结论

从静脉和主动脉的两个图像导出输入函数的双组织房室动力学模型得出的几个模型参数,使用SUV能够区分通过使用FAPI的动态PET扫描获得的HCC和非HCC病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/e3b38701fdc2/40658_2021_353_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/9a6b5c7b37b5/40658_2021_353_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/11d2e3fe0801/40658_2021_353_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/a82f8d22a72f/40658_2021_353_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/e3b38701fdc2/40658_2021_353_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/9a6b5c7b37b5/40658_2021_353_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/11d2e3fe0801/40658_2021_353_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/a82f8d22a72f/40658_2021_353_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad92/7822999/e3b38701fdc2/40658_2021_353_Fig4_HTML.jpg

相似文献

1
A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic Ga-FAPI-04 PET/CT imaging.一项关于健康组织、肝细胞癌及其他病变的动态镓- FAPI - 04 PET/CT成像的方法学研究。
EJNMMI Phys. 2021 Jan 22;8(1):8. doi: 10.1186/s40658-021-00353-y.
2
Comparison of different kinetic models for dynamic F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input function.比较不同动力学模型用于不同的、也包括双血输入函数的肝细胞癌动态 F-FDG PET/CT 成像。
Phys Med Biol. 2020 Feb 10;65(4):045001. doi: 10.1088/1361-6560/ab66e3.
3
Dynamic F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function.动态 F-FDG PET 肝脏病灶显像:双输入函数双室模型的评估。
BMC Med Imaging. 2021 May 25;21(1):90. doi: 10.1186/s12880-021-00623-2.
4
Ga-FAPI-04 Versus F-FDG PET/CT in the Detection of Hepatocellular Carcinoma.镓标记的FAPI-04与氟代脱氧葡萄糖PET/CT在肝细胞癌检测中的比较
Front Oncol. 2021 Jun 25;11:693640. doi: 10.3389/fonc.2021.693640. eCollection 2021.
5
Kinetic analysis of dynamic (11)C-acetate PET/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions.动态(11)C-乙酸盐PET/CT成像的动力学分析作为鉴别肝细胞癌和肝脏良性病变的潜在方法
Theranostics. 2015 Jan 21;5(4):371-7. doi: 10.7150/thno.10760. eCollection 2015.
6
Fibroblast imaging of hepatic carcinoma with Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.Ga-FAPI-04 PET/CT 对肝癌成纤维细胞显像:疑似肝结节患者的初步研究。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):196-203. doi: 10.1007/s00259-020-04882-z. Epub 2020 May 29.
7
Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study.镓-前列腺特异性膜抗原是一种用于肝细胞癌成像的新型正电子发射断层扫描-计算机断层扫描示踪剂:一项前瞻性试点研究。
J Nucl Med. 2019 Feb 1;60(2):185-191. doi: 10.2967/jnumed.118.214833. Epub 2018 Jul 12.
8
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT:不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
9
Value of F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma.F-FDG PET/CT 在肝细胞癌患者门静脉癌栓诊断中的价值。
Abdom Radiol (NY). 2019 Jul;44(7):2430-2435. doi: 10.1007/s00261-019-01997-2.
10
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.利用 Ga 标记的成纤维细胞激活蛋白抑制剂 FAPI-04 对心肌梗死后成纤维细胞活性进行分子成像。
J Nucl Med. 2019 Dec;60(12):1743-1749. doi: 10.2967/jnumed.119.226993. Epub 2019 Aug 12.

引用本文的文献

1
Dual-phase multiobjective Bayesian optimization method for estimating hepatocellular carcinoma dynamics parameters from PET/CT scans.基于PET/CT扫描估计肝细胞癌动力学参数的双相多目标贝叶斯优化方法
Quant Imaging Med Surg. 2025 Aug 1;15(8):6654-6666. doi: 10.21037/qims-2024-2767. Epub 2025 Jul 29.
2
Emerging theragnostic radionuclide applications for hepatocellular carcinoma.用于肝细胞癌的新兴治疗诊断放射性核素应用
Front Nucl Med. 2023 Oct 25;3:1210982. doi: 10.3389/fnume.2023.1210982. eCollection 2023.
3
Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review.

本文引用的文献

1
Fibroblast imaging of hepatic carcinoma with Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.Ga-FAPI-04 PET/CT 对肝癌成纤维细胞显像:疑似肝结节患者的初步研究。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):196-203. doi: 10.1007/s00259-020-04882-z. Epub 2020 May 29.
2
Comparison of different kinetic models for dynamic F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input function.比较不同动力学模型用于不同的、也包括双血输入函数的肝细胞癌动态 F-FDG PET/CT 成像。
Phys Med Biol. 2020 Feb 10;65(4):045001. doi: 10.1088/1361-6560/ab66e3.
3
Tumour evolution in hepatocellular carcinoma.
基于成纤维细胞激活蛋白抑制剂的 PET/CT 对原发性和转移性肝脏肿瘤患者的诊断性能:一项全面的文献综述。
Int J Mol Sci. 2024 Jun 29;25(13):7197. doi: 10.3390/ijms25137197.
4
Beyond stillness: the importance of tackling patient's motion for reliable parametric imaging.超越静止:解决患者运动对可靠参数成像的重要性。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1210-1212. doi: 10.1007/s00259-024-06592-2.
5
FAPI PET/CT Imaging-An Updated Review.FAPI PET/CT成像——最新综述
Diagnostics (Basel). 2023 Jun 9;13(12):2018. doi: 10.3390/diagnostics13122018.
6
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.用于肝细胞癌成像的正电子发射断层显像(PET)放射性药物的最新进展
Cancers (Basel). 2023 Mar 25;15(7):1975. doi: 10.3390/cancers15071975.
7
Three-Time-Point PET Analysis of Ga-FAPI-46 in a Variety of Cancers.多种癌症中镓标记的FAPI-46的三时间点PET分析
J Nucl Med. 2023 Apr;64(4):618-622. doi: 10.2967/jnumed.122.264941. Epub 2022 Nov 10.
8
Different Features of F-FAPI, F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the Literature.¹⁸F-FAPI、¹⁸F-FDG PET/CT及MRI在评估肝外转移及局部复发性肝细胞癌(HCC)中的不同特征:1例病例报告及文献复习
Cancer Manag Res. 2022 Sep 5;14:2649-2655. doi: 10.2147/CMAR.S374916. eCollection 2022.
9
The Application of [Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.[Ga]-标记 FAPI-04 PET/CT 在患者来源的原位异种移植模型中用于胰腺癌细胞靶向和早期检测的应用。
Contrast Media Mol Imaging. 2022 Aug 5;2022:6596702. doi: 10.1155/2022/6596702. eCollection 2022.
10
Static and Dynamic Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas.静态和动态 Ga-FAPI PET/CT 用于检测胰腺导管内乳头状黏液性肿瘤的恶性转化。
J Nucl Med. 2023 Feb;64(2):244-251. doi: 10.2967/jnumed.122.264361. Epub 2022 Jul 29.
肝细胞癌中的肿瘤演进。
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):139-152. doi: 10.1038/s41575-019-0229-4. Epub 2019 Dec 2.
4
FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis.FAPI-PET/CT改善了一名脑转移肺癌患者的分期。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1754-1755. doi: 10.1007/s00259-019-04346-z. Epub 2019 May 22.
5
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.镓-FAPI PET/CT:28 种不同癌症的示踪剂摄取。
J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.
6
Performance evaluation of a new high-sensitivity time-of-flight clinical PET/CT system.新型高灵敏度飞行时间临床PET/CT系统的性能评估
EJNMMI Phys. 2018 Dec 1;5(1):29. doi: 10.1186/s40658-018-0229-4.
7
Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.成纤维细胞激活蛋白:靶向肿瘤微环境的根源
J Nucl Med. 2018 Sep;59(9):1412-1414. doi: 10.2967/jnumed.118.214361. Epub 2018 Aug 10.
8
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT:不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
9
Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects.在健康受试者中使用动态FDG-PET/MRI评估肾功能参数肾小球滤过率和有效肾血浆流量。
EJNMMI Res. 2018 May 9;8(1):37. doi: 10.1186/s13550-018-0389-1.
10
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.一种针对肿瘤相关成纤维细胞的肿瘤成像方法。
J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6.